Analyst: Zealand Pharma pipeline will be crucial
![Photo: Zealand Pharma / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13822940.ece/ALTERNATES/schema-16_9/doc7k46um7n87mnksi95ob.jpg)
The potential of Zealand Pharma’s drug pipeline has been overlooked, according US-based investment bank Jefferies, which maintains its ”buy” recommendation for the biotech company.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Zealand Pharma reports higher costs in 2021
For subscribers
Zealand Pharma finishes phase III enrollment
For subscribers
Founder steps down from CEO role at Beta Bionics
For subscribers